Ontology highlight
ABSTRACT: Objective
Attention bias modification (ABM) aims to decrease anxiety symptom severity through the reduction of threat-related attention bias (AB). Individual differences in treatment response and poor measurement reliability of AB have called its clinical promise into question. The current study examined whether individual differences in anxiety severity at baseline moderated treatment response, and employed both behavioral and neurophysiological metrics of AB.Methods
Participants (N = 99) were randomly assigned to four weeks of ABM or placebo control training (PT). Self-reported anxiety symptom severity, and AB metrics and ERPs generated during the dot probe task were collected at baseline (Time 1), one-week post-intervention (Time 5), and at a three-month follow-up (Time 6).Results
ABM, relative to PT, reduced ERPs indexing attention discrimination (N170) and increased ERPs indexing salience tracking (P3). Increases in P3 were associated with ABM-related reductions in anxiety. Anxiety severity was reduced following ABM, but only among those with higher baseline anxiety symptom severity.Conclusions
ABM effectively reduced symptom severity among those with higher levels of anxiety, and modulated neurophysiological indices of AB.Significance
Results provide evidence for attention-relevant ERPs as outcomes of ABM treatment responsivity and suggest that ABM may be most beneficial for those with more severe anxiety symptoms.
SUBMITTER: Dennis Tiwary TA
PROVIDER: S-EPMC9974920 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature
Dennis Tiwary Tracy A TA Cho Hyein H Myruski Sarah S
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20221229
<h4>Objective</h4>Attention bias modification (ABM) aims to decrease anxiety symptom severity through the reduction of threat-related attention bias (AB). Individual differences in treatment response and poor measurement reliability of AB have called its clinical promise into question. The current study examined whether individual differences in anxiety severity at baseline moderated treatment response, and employed both behavioral and neurophysiological metrics of AB.<h4>Methods</h4>Participant ...[more]